Deerfield + University of Illinois Urbana-Champaign: Collaborating to Advance Biomedical Innovation

- Sponsor
- Deerfield
- Views
- 193
- Originating Calendar
- Carl R. Woese Institute for Genomic Biology
How do academic investigators work with investors to turn promising scientific ideas into real-world companies?
Please join us for a conversation with the Deerfield team to explore their work in advancing academic innovation through Deerfield’s partnership with Illinois. Deerfield is an investment firm dedicated to advancing healthcare through investment, intelligence, and philanthropy. The firm's internal drug discovery and development group, 3DC, is a partner to various stakeholders in the biotech ecosystem, including principal investigators in Deerfield’s academic collaboration network, as well as startups, and biopharma companies.
What you’ll learn:
- How Deerfield and 3DC partner with academic medical centers and aim to turn research and clinical ideas into real-world healthcare innovations and new biotech ventures
- What capabilities and resources Deerfield can bring to help enable productive partnerships with Illinois scientists and clinicians
- What Deerfield’s areas of interest are for academic collaborations, and how to engage
Members of the Illinois biomedical ecosystem likely to find this most interesting:
- Faculty, students, and staff involved in translational research
- Clinicians and medical center leaders interested in industry collaborations
- Biomedical innovation leaders and entrepreneurs
SPEAKERS
- Nadim Shohdy, Ph.D., Chief Operating Officer, Deerfield Discovery and Development
- William Slattery, Partner, Therapeutics Investment Team